SKI Market

Indian Indices

Sensex

82,626.76 -1,048.16
( -1.25%)

Global Indices

Nasdaq

49,514.94 41.95
(0.08%)

Dow Jones

6,856.39 2.63
(0.04%)

Hang Seng

57,040.53 -599.31
(-1.04%)

Nikkei 225

10,448.94 46.50
(0.45%)

Forex

USD-INR

90.59 -0.07
(-0.07%)

EUR-INR

107.56 -0.26
(-0.24%)

GBP-INR

123.48 -0.32
(-0.26%)

JPY-INR

0.59 0.00
(0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

State Bank of India

Industry : Banks - Public Sector

BSE Code

ISIN Demat

Book Value()

500112

INE062A01020

555.3957794

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SBIN

14.66

1106566.44

EPS(TTM)

Face Value()

Div & Yield %

81.79

1.28

Back

smt engineering ltd

Welcure Drugs & Pharmaceuticals standalone net profit rises 361.96% in the September 2025 quarter

Nov 14,2025

Net profit of Welcure Drugs & Pharmaceuticals rose 361.96% to Rs 8.50 crore in the quarter ended September 2025 as against Rs 1.84 crore during the previous quarter ended September 2024. Sales rose 167.29% to Rs 65.62 crore in the quarter ended September 2025 as against Rs 24.55 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	65.62	24.55	167
OPM %	17.31	7.54	-
PBDT	11.36	1.85	514
PBT	11.36	1.84	517
NP	8.50	1.84	362

82,626.76 -1,048.16 ( -1.25%)

49,514.94 41.95 (0.08%)

6,856.39 2.63 (0.04%)

57,040.53 -599.31 (-1.04%)

10,448.94 46.50 (0.45%)

90.59 -0.07 (-0.07%)

107.56 -0.26 (-0.24%)

123.48 -0.32 (-0.26%)

0.59 0.00 (0.20%)